Find Bentonite manufacturers, exporters & distributors on PharmaCompass

Virtual Booth

ACCESS ALL DATA
Browse all information
CHEMISTRY
Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

1 NDC API, $ API Reference Price

1 NDC API
$ API Reference Price

DEVELOPMENTS

4 Drugs in Development

4 Drugs in Development

FINISHED DOSAGE FORMULATIONS

1 FDF Dossiers, 1 FDA Orange Book

1 FDF Dossiers
1 FDA Orange Book

DIGITAL CONTENT

2 DATA COMPILATION #PharmaFlow

media
2 DATA COMPILATION #PharmaFlow

MARKET PLACE

5 APIs

marketPlace
5 APIs

Synopsis

ACTIVE PHARMA INGREDIENTS

API Suppliers

USDMF

CEP/COS

JDMF

EU WC

KDMF

NDC API

VMF

Listed Suppliers

API REF. PRICE (USD/KG)

MARKET PLACE

API

FDF

0INTERMEDIATES

FINISHED DOSAGE FORMULATIONS

FDF Dossiers

FDA Orange Book

Europe

Canada

Australia

South Africa

Listed Dossiers

DRUG PRODUCT COMPOSITIONS

REF. STANDARDS OR IMPURITIES

EDQM

USP

Others

PATENTS & EXCLUSIVITIES

US Patents

US Exclusivities

Health Canada Patents

DIGITAL CONTENT

Data Compilation #PharmaFlow

Stock Recap #PipelineProspector

Weekly News Recap #Phispers

News #PharmaBuzz

GLOBAL SALES INFORMATION

US Medicaid (USD)

Annual Reports (USD Million)

Finished Drug Prices

0RELATED EXCIPIENT COMPANIES

0EXCIPIENTS BY APPLICATIONS

Chemistry

Click the arrow to open the dropdown

Click the button for full data set

Also known as: Benclay, Bentolite l, Bentone 34, Aquagel, Askangel, Magbond

Molecular Formula

Al₂H₂O₆Si

Molecular Weight

180.06 g/mol

InChI Key

SVPXDRXYRYOSEX-UHFFFAOYSA-N

Bentoquatam is a topical medication intended to act as a shield against exposure to the irritating substance urushiol, found in plants such as poison ivy or poison oak. Bentoquatam contains bentonite, a clay, and is only effective as long as the film is visible on the skin.

1 2D Structure

Bentonite

2 Identification

2.1 Computed Descriptors

2.1.1 IUPAC Name

dioxosilane;oxo(oxoalumanyloxy)alumane;hydrate

2.1.2 InChI

InChI=1S/2Al.O2Si.H2O.3O/c;;1-3-2;;;;/h;;;1H2;;;

2.1.3 InChI Key

SVPXDRXYRYOSEX-UHFFFAOYSA-N

2.1.4 Canonical SMILES

O.O=[Al]O[Al]=O.O=[Si]=O

2.2 Synonyms

2.2.1 MeSH Synonyms

1. Bentone 34

2. Dimethyldioctadecylammonium Montmorillonite

3. Ivy Block

4. Quaternium 18-bentonite

2.2.2 Depositor-Supplied Synonyms

1. Benclay

2. Bentolite L

3. Bentone 34

4. Aquagel

5. Askangel

6. Magbond

7. Otaylite

8. Tixoton

9. Volclay

10. Wilkinite

11. Bengel

12. Culvin

13. Filgel

14. Akajo

15. Asama

16. Bentogrout

17. Soap Clay

18. Bentonit T

19. Bentolite Hs

20. Bulgarben Ba

21. Accugel F

22. Altonit Sf

23. Bengel A

24. Bengel Fw

25. Southern Bentonite

26. Bengel Hvp

27. Bentosolon 82

28. Aquagel Gold Seal

29. Detercal G 1fc

30. Detercal G 2fc

31. Detercol P 2

32. Bentone 27

33. Accofloc 352

34. Cosintam 403

35. Hi-jel

36. Bengel 11

37. Bengel 15

38. Bengel 23

39. Bentonite 2073

40. Bentone 660

41. Cvis

42. Fulbent 570

43. Volcaly Bentonite Bc

44. Aluminosilicate Hydrate

45. Imvite I.g.b.a

46. Bentonite [jan:nf]

47. Bentonite, Sodium Form

48. Panther Creek Bentonite

49. Clarit Bw 100

50. Clarit Bw 125

51. Black Hills Bh 200

52. Bentonite, Calcian-sodian

53. Unii-a3n5zcn45c

54. G 100 (clay)

55. Ex 0030 (clay)

56. Albagel Premium Usp 4444

57. Ccris 3663

58. Hsdb 392

59. Gk 129sa3

60. Gk 129sa5

61. Aeg 325

62. Ex-m 703

63. Einecs 215-108-5

64. Mfcd00130611

65. Ex 0276

66. 250m

67. Dioxosilane;oxo(oxoalumanyloxy)alumane;hydrate

68. Q20817027

2.3 Create Date

2005-03-27

3 Chemical and Physical Properties

Molecular Formula	Al₂H₂O₆Si
Molecular Weight	180.06 g/mol
Hydrogen Bond Donor Count	1
Hydrogen Bond Acceptor Count	6
Rotatable Bond Count	0
Exact Mass	179.925141 g/mol
Monoisotopic Mass	179.925141 g/mol
Topological Polar Surface Area	78.5 Å²
Heavy Atom Count	9
Formal Charge	0
Complexity	52.4
Isotope Atom Count	0
Defined Atom Stereocenter Count	0
Undefined Atom Stereocenter Count	0
Defined Bond Stereocenter Count	0
Undefined Bond Stereocenter Count	0
Covalently Bonded Unit Count	3

4 Drug and Medication Information

4.1 Drug Information

1 of 2
Drug Name	Ivy block
Active Ingredient	Bentoquatam
Dosage Form	Lotion
Route	Topical
Strength	5%
Market Status	Over the Counter
Company	Stand Homeopath

2 of 2
Drug Name	Ivy block
Active Ingredient	Bentoquatam
Dosage Form	Lotion
Route	Topical
Strength	5%
Market Status	Over the Counter
Company	Stand Homeopath

4.2 Drug Indication

Used to prevent or reduce the severity of allergic contact dermatitis due to urushiol, the allergenic resin of poison ivy, poison oak, and poison sumac.

5 Pharmacology and Biochemistry

5.1 Pharmacology

Bentoquatam protects the skin like a shield against poison ivy, poison oak, and poison sumac by physically blocking skin contact with their resin. The best protection against getting these conditions is to avoid contact with these plants. This medicine does not dry oozing and weeping caused by the rash of poison ivy, poison oak, or poison sumac.

5.2 MeSH Pharmacological Classification

Dermatologic Agents

Drugs used to treat or prevent skin disorders or for the routine care of skin. (See all compounds classified as Dermatologic Agents.)

5.3 Mechanism of Action

The mechanism of action is unknown. It is thought topically applied bentoquatam acts as a physical barrier that interferes with the adsorption of antigens onto the skin and reduces absorption of antigens into the skin. It probably does not work by modifying the systemic allergic response.

NDC API

FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

API Reference Price

[{"dataSource":"API Export","activeIngredients":"","year":"2023","qtr":"Q2","strtotime":1683829800,"product":"RAW MATERIALS FOR CONSTRUCTION CHEMIICALS MFG INDUSTRIES SMECTONE CLAY HR BENTONITE MONTMORILLONITE CLAY API","address":"73A GANESH CHANDRA AVENUE,3RD FLOO R","city":"KOLKATA,WEST BENGAL","supplier":"JANMENJOY PRAMANIK INTERNATIONAL PRIVATE LIMITED","supplierCountry":"INDIA","foreign_port":"BENAPOLE","customer":"EASTERN BANK LIMITED","customerCountry":"BANGLADESH","quantity":"100.00","actualQuantity":"100","unit":"KGS","unitRateFc":"2.8","totalValueFC":"279.5","currency":"USD","unitRateINR":230,"date":"12-May-2023","totalValueINR":"23000","totalValueInUsd":"279.5","indian_port":"PETRAPOLE ROAD","hs_no":"29319090","bill_no":"0","productDescription":"API","marketType":"LESS REGULATED MARKET","country":"BANGLADESH","selfForZScoreResived":"Pharma Grade","supplierPort":"PETRAPOLE ROAD","supplierAddress":"73A GANESH CHANDRA AVENUE,3RD FLOO R, KOLKATA,WEST BENGAL","customerAddress":""},{"dataSource":"API Export","activeIngredients":"","year":"2023","qtr":"Q4","strtotime":1696876200,"product":"BENTONITE CLAY (OTHER DETAIL AS PER INVOICE AND P.LIST)","address":"39-KRISHNA MARKET,SHIVAJI PARK","city":"NEW DELHI","supplier":"SMK PETRO CHEMICALS INDIA PRIVATE LIMITED.","supplierCountry":"INDIA","foreign_port":"DURBAN","customer":"TRUE LUBRICANTS & SUPPLIES PTY LTD","customerCountry":"SOUTH AFRICA","quantity":"10000.00","actualQuantity":"10000","unit":"KGS","unitRateFc":"2.6","totalValueFC":"25555.9","currency":"USD","unitRateINR":212.69999999999999,"date":"10-Oct-2023","totalValueINR":"2127000","totalValueInUsd":"25555.9","indian_port":"Mundra","hs_no":"29319090","bill_no":"4539076","productDescription":"API","marketType":"LESS REGULATED MARKET","country":"SOUTH AFRICA","selfForZScoreResived":"Pharma Grade","supplierPort":"Mundra","supplierAddress":"39-KRISHNA MARKET,SHIVAJI PARK, NEW DELHI","customerAddress":""},{"dataSource":"API Export","activeIngredients":"","year":"2024","qtr":"Q2","strtotime":1712687400,"product":"FRGEL GR(BENTONITE CLAYS)","address":"39-KRISHNA MARKET,SHIVAJI PARK","city":"NEW DELHI","supplier":"SMK PETRO CHEMICALS INDIA PRIVATE LIMITED.","supplierCountry":"INDIA","foreign_port":"","customer":"AXCL GULF FZC","customerCountry":"UNITED ARAB EMIRATES","quantity":"1500.00","actualQuantity":"1500","unit":"KGS","unitRateFc":"3.3","totalValueFC":"4869.4","currency":"USD","unitRateINR":271.08785333333333,"date":"10-Apr-2024","totalValueINR":"406631.78","totalValueInUsd":"4869.4","indian_port":"JNPT","hs_no":"29319090","bill_no":"9028444","productDescription":"API","marketType":"LESS REGULATED MARKET","country":"UNITED ARAB EMIRATES","selfForZScoreResived":"Pharma Grade","supplierPort":"JNPT","supplierAddress":"39-KRISHNA MARKET,SHIVAJI PARK, NEW DELHI","customerAddress":""},{"dataSource":"API Export","activeIngredients":"","year":"2024","qtr":"Q2","strtotime":1712687400,"product":"FRGEL GR(BENTONITE CLAYS)","address":"39-KRISHNA MARKET,SHIVAJI PARK","city":"NEW DELHI","supplier":"SMK PETRO CHEMICALS INDIA PRIVATE LIMITED.","supplierCountry":"INDIA","foreign_port":"JEBEL ALI","customer":"AXCL GULF FZC","customerCountry":"UNITED ARAB EMIRATES","quantity":"1500.00","actualQuantity":"1500","unit":"KGS","unitRateFc":"3.3","totalValueFC":"4869.4","currency":"USD","unitRateINR":271.08785333333333,"date":"10-Apr-2024","totalValueINR":"406631.78","totalValueInUsd":"4869.4","indian_port":"JNPT","hs_no":"29319090","bill_no":"9028095","productDescription":"API","marketType":"LESS REGULATED MARKET","country":"UNITED ARAB EMIRATES","selfForZScoreResived":"Pharma Grade","supplierPort":"JNPT","supplierAddress":"39-KRISHNA MARKET,SHIVAJI PARK, NEW DELHI","customerAddress":""},{"dataSource":"API Import","activeIngredients":"BENTONITE","year":"2021","qtr":"Q2","strtotime":1620757800,"product":"KATALYSATOR K 10-S (NATURAL CA-BENTONITE, ACID ACTIVITED) (NOT INTENDED FOR FOOD AND MEDICINE USE)","address":"MOUZA-CHANDI,DIAMOND HARBOURROAD,P.S.;BISHNUPUR,","city":"DIST.24PGS(S), W.B.","supplier":"WACKER CHEMIE AG","supplierCountry":"GERMANY","foreign_port":"HAMBURG","customer":"WACKER CHEMIE AG","customerCountry":"INDIA","quantity":"10000.00","actualQuantity":"10000","unit":"KGS","unitRateFc":"2.7","totalValueFC":"27757.2","currency":"USD","unitRateINR":"203.3","date":"12-May-2021","totalValueINR":"2033200","totalValueInUsd":"27757.2","indian_port":"KOLKATA","hs_no":"29163990","bill_no":"3914862","productDescription":"API","marketType":"REGULATED MARKET","country":"GERMANY","selfForZScoreResived":"Pharma Grade","supplierPort":"HAMBURG","supplierAddress":"","customerAddress":"MOUZA-CHANDI,DIAMOND HARBOURROAD,P.S.;BISHNUPUR,"},{"dataSource":"API Import","activeIngredients":"","year":"2021","qtr":"Q3","strtotime":1628879400,"product":"TA-40 (ALKYL QUATERNARY AMMONIUM BENTONITE>99%+QUARTZ<0.5%)(RUST PREVENTIVE ADDITIVE)(CAPTIVE CONSUMPTION)","address":"E-4,JHULELAL APPT. ROAD NO. 44 PITAMPURA","city":"NEW DELHI","supplier":"NIHON PARKERIZING CO. ","supplierCountry":"JAPAN","foreign_port":"YOKOHAMA","customer":"NIHON PARKERIZING INDIA ","customerCountry":"INDIA","quantity":"75.00","actualQuantity":"75","unit":"KGS","unitRateFc":"615","totalValueFC":"428.8","currency":"JPY","unitRateINR":"424","date":"14-Aug-2021","totalValueINR":"31803.19","totalValueInUsd":"428.8","indian_port":"JNPT","hs_no":"29239000","bill_no":"5048609","productDescription":"API","marketType":"REGULATED MARKET","country":"JAPAN","selfForZScoreResived":"Pharma Grade","supplierPort":"YOKOHAMA","supplierAddress":"","customerAddress":"E-4,JHULELAL APPT. ROAD NO. 44 PITAMPURA"},{"dataSource":"API Import","activeIngredients":"","year":"2022","qtr":"Q1","strtotime":1643394600,"product":"TA-40 (ALKYL QUATERNARY AMMONIUM BENTONITE>99%+QUARTZ<0.5%)(RUST PREVENTIVE ADDITIVE)(CAPTIVE CONSUMPTION)","address":"PLOT NO -127, IST FLOOR, SECTOR 44 ,GURGAON, HARYANA","city":"GURGAON,HARYANA","supplier":"NIHON PARKERIZING CO. ","supplierCountry":"JAPAN","foreign_port":"YOKOHAMA","customer":"NIHON PARKERIZING INDIA ","customerCountry":"INDIA","quantity":"50.00","actualQuantity":"50","unit":"KGS","unitRateFc":"615","totalValueFC":"273.5","currency":"JPY","unitRateINR":"407.4","date":"29-Jan-2022","totalValueINR":"20371.88","totalValueInUsd":"273.5","indian_port":"JNPT","hs_no":"29239000","bill_no":"7283509","productDescription":"API","marketType":"REGULATED MARKET","country":"JAPAN","selfForZScoreResived":"Pharma Grade","supplierPort":"YOKOHAMA","supplierAddress":"","customerAddress":"PLOT NO -127, IST FLOOR, SECTOR 44 ,GURGAON, HARYANA"},{"dataSource":"API Import","activeIngredients":"","year":"2022","qtr":"Q2","strtotime":1653071400,"product":"TA-40 (ALKYL QUATERNARY AMMONIUM BENTONITE>99%+QUARTZ<0.5%)(RUST PREVENTIVE ADDITIVE)(CAPTIVE CONSUMPTION)","address":"PLOT NO -127, IST FLOOR, SECTOR 44 ,GURGAON, HARYANA","city":"GURGAON,HARYANA","supplier":"NIHON PARKERIZING CO. ","supplierCountry":"JAPAN","foreign_port":"NA","customer":"NIHON PARKERIZING INDIA ","customerCountry":"INDIA","quantity":"75.00","actualQuantity":"75","unit":"KGS","unitRateFc":"615","totalValueFC":"366.4","currency":"JPY","unitRateINR":"377.6","date":"21-May-2022","totalValueINR":"28320.75","totalValueInUsd":"366.4","indian_port":"JNPT","hs_no":"29239000","bill_no":"8776235","productDescription":"API","marketType":"REGULATED MARKET","country":"JAPAN","selfForZScoreResived":"Pharma Grade","supplierPort":"NA","supplierAddress":"","customerAddress":"PLOT NO -127, IST FLOOR, SECTOR 44 ,GURGAON, HARYANA"},{"dataSource":"API Import","activeIngredients":"","year":"2023","qtr":"Q1","strtotime":1677263400,"product":"TA-40 (ALKYL QUATERNARY AMMONIUM BENTONITE>99%+QUARTZ<0.5%)(RUST PREVENTIVE ADDITIVE)(CAPTIVE CONSUMPTION)","address":"PLOT NO -127, IST FLOOR, SECTOR 44 ,GURGAON, HARYANA","city":"GURGAON,HARYANA","supplier":"NIHON PARKERIZING CO. ","supplierCountry":"JAPAN","foreign_port":"NA","customer":"NIHON PARKERIZING INDIA ","customerCountry":"INDIA","quantity":"50.00","actualQuantity":"50","unit":"KGS","unitRateFc":"615","totalValueFC":"234.4","currency":"JPY","unitRateINR":"387.1","date":"25-Feb-2023","totalValueINR":"19357.13","totalValueInUsd":"234.4","indian_port":"JNPT","hs_no":"29239000","bill_no":"4803949","productDescription":"API","marketType":"REGULATED MARKET","country":"JAPAN","selfForZScoreResived":"Pharma Grade","supplierPort":"NA","supplierAddress":"","customerAddress":"PLOT NO -127, IST FLOOR, SECTOR 44 ,GURGAON, HARYANA"}]

Number of Transactions

Total Quantity (KGS)

Total Value (USD)

Quantity (KGS) & Unit rate (USD/KGS) over time

API Imports and Exports

Importing Country	Total Quantity (KGS)	Average Price (USD/KGS)	Number of Transactions

Upgrade, download data, analyse, strategize, subscribe with us contact

Drugs in Development

01 Altamira Therapeutics

Bermuda

SupplySide West 2024

Not Confirmed

02 Pharma Nordic

Norway

SupplySide West 2024

Not Confirmed

03 Pharma Nordic

Norway

SupplySide West 2024

Not Confirmed

04 Nuance Pharma

China

SupplySide West 2024

Not Confirmed

FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

FDF Dossiers

FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

FDA Orange Book

01

STAND HOMEOPATH

Country

World Vaccine Congress

Not Confirmed

FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

Digital Content

Create Content with PharmaCompass, ask us

DATA COMPILATION #PharmaFlow

Excipient Market Overview: Roquette, Seqens, Evonik make strategic moves; new guidelines deal with contamination

The pharmaceutical industry has long recognized the critical role excipients or inactive ingredients play in drug formulation and delivery. Excipients can comprise up to 90 percent of a medicine's total ingredients and serve crucial functions as binders, disintegrants, coatings, preservatives, colors, and flavorings. According to recent market research, the pharmaceutical excipients market was valued at US$ 9.27 billion in 2023. It is growing at a compound annual growth rate (CAGR) of 7.03 percent and is projected to reach US$ 18.48 billion by 2032. The main factors driving market growth is an increased demand for multifunctional excipients, coupled with the expanding use of generic medications. The development in the biologics sector and advancements in nanotechnology are also contributing significantly to market growth. Major excipient providers include BASF, Evonik, Merck KGaA owned MilliporeSigma, Gangwal Healthcare, Roquette Frères, DuPont, Croda International, Seqens, Boai NKY Pharmaceuticals, PMC Isochem, Minakem, Kewpie Corporation, Ashland Global, SPI Pharma, Pfanstiehl, Nanjing Well Pharmaceutical, ICE Pharma, Anhui Ribobay Pharmaceutical and Nippon Fine Chemical. View Our Dashboard on Major Excipient Companies in 2024 (Free Excel Available) WHO, India’s CDSCO tighten regulations; new GMP guidelines implemented to curb contamination Last year, the World Health Organization (WHO) issued a health alert linking at least 300 child deaths in the Gambia, Uzbekistan, and Indonesia to the ingestion of contaminated cough syrups containing unacceptable levels of diethylene glycol (DEG) and ethylene glycol (EG). In response to the tragic events, the WHO released two draft appendices to its guideline on good manufacturing practices (GMPs) for excipients this year. Manufacturers are now required to use suitable risk assessment tools to identify and mitigate potential hazards. Since India-made cough syrups had been linked to the deaths, India’s drug regulator — Central Drugs Standard Control Organization (CDSCO) — took steps to prevent contamination, and advised drugmakers to only use pharmaceutical-grade excipients from approved sources. Furthermore, the Indian Health Ministry proposed amendments to the Drugs and Cosmetics Rules, 1945 to include details of excipients on drug labels. While listing all excipients on every strip of medicine may be challenging, the ministry suggested mentioning those causing hypersensitivity on the label. Applicants now mandatorily need to submit evidence of stability and safety of excipients. These regulatory developments have significant implications for excipient manufacturers and pharmaceutical companies worldwide. Leading pharmaceutical excipient firms like Gangwal Healthcare, Sigachi Industries, and Nitika Pharmaceuticals are well-positioned to meet these heightened quality and safety standards, given their long-standing commitment to producing high-quality, compliant excipients. View Our Dashboard on Major Excipient Companies in 2024 (Free Excel Available) Roquette buys IFF’s pharma unit for US$ 2.85 bn; Evonik opens new spray-drying facility in Darmstadt In a significant industry move, France-based Roquette entered into an agreement to acquire IFF's pharma solutions business in a deal valued at US$ 2.85 billion. This acquisition is set to rebalance family-owned Roquette’s portfolio around health and nutrition. The deal is expected to accelerate Roquette’s growth and significantly strengthen its presence in the excipients market. Evonik has opened a new facility for drying aqueous dispersions of its Eudragit polymers at its site in Darmstadt, Germany. The facility will help Evonik meet increasing demand from drugmakers for its oral drug delivery solutions. The plant uses green energy solutions. The company has also partnered University of Mainz to commercialize a new class of polyethylene glycols (PEG) lipids for nucleic acid delivery. Evonik’s Health Care business has been growing its nucleic acid drug and vaccine delivery portfolio. Germany’s Johannes Gutenberg University of Mainz was the first to develop randomized polyethylene glycols (rPEGs). This collaboration aims to expand Evonik’s toolbox of technologies for nucleic acid-based medicines, offering an improved immunogenicity profile for lipid nanoparticle carriers used in mRNA vaccines and therapeutics. Asahi Kasei made significant strides in addressing a pressing industry concern that emerged in 2018 when potentially carcinogenic nitrosamine impurities were detected in several pharmaceuticals. Guided by regional authorities, such as the European Medicines Agency and the US Food and Drug Administration, the pharmaceutical industry has been carrying out extensive assessments and research to identify the cause of these impurities. In response to this challenge, Asahi Kasei developed its Ceolus microcrystalline cellulose with extremely low nitrite levels. The Japanese company achieved nitrite concentrations of 0.1 micrograms per gram or less, which is equivalent to 0.1 parts per million (ppm). The company also started full commercial operation of its second manufacturing facility for Ceolus in Japan, enhancing supply capacity and stability. JRS Pharma and Gujarat Microwax opened a state-of-the-art cotton-based croscarmellose sodium plant in Mehsana, Gujarat (India). This facility aims to produce high-quality excipients that meet global standards, potentially reducing India's dependency on imports and boosting its presence in the global excipient market. The Indian excipient industry accounts for less than 1 percent of the global market share. View Our Dashboard on Major Excipient Companies in 2024 (Free Excel Available) Seqens to advance innovative polymer; biologics, personalized medicine create demand for specialized excipients Recent industry collaborations highlight the ongoing innovation in novel excipients. France’s Seqens, with over 20 years of polymer development experience, was chosen by Pleryon Therapeutics to advance its leading osteoarthritis candidate – an innovative GMP polymer. This collaboration leverages Seqens’ newly expanded and modernized cGMP plant in Aramon, France, demonstrating the industry’s commitment to investing in advanced manufacturing capabilities for novel excipients. The rise of biologics and personalized medicine has created a demand for specialized excipients capable of stabilizing complex molecules and enabling targeted drug delivery. Roquette’s launch of Lycagel Flex, a hydroxypropyl pemix for nutraceutical and pharmaceutical softgel capsules, exemplifies this trend. Built on Roquette’s market-first Lycagel pea starch technology, this plant-based alternative to gelatin offers manufacturers the flexibility to customize formulations for a range of production and end-user needs. The innovative pea starch foundation also underscores the industry’s move towards sustainable bio-based excipients. The trend towards patient-centric drug development has also influenced excipient innovation. Excipients that can improve palatability, ease of swallowing, or enable novel dosage forms (such as orally disintegrating tablets) are in high demand. For example, IFF brought a super disintegrant Ac-Di-Sol, that supports faster disintegration and drug dissolution in oral disintegrating tablets, improving patient experience. View Our Dashboard on Major Excipient Companies in 2024 (Free Excel Available) Our view The heightened regulatory scrutiny on excipients due to product contamination incidents has created a high risk perception and uncertainty around the regulatory acceptance of novel excipients. That said, novel excipients are central to the development of new drug modalities and therapies. Going forward, sustainability will also become an increasingly important factor in excipient selection and development. As the industry innovates towards biologics, personalized therapies, and patient-centric formulations, the role of high-quality, multifunctional excipients will only grow more vital in ensuring drug stability, bioavailability, and patient compliance. Companies that can navigate the complex regulatory landscape, invest in R&D, and offer high-quality, multifunctional excipients will be well-positioned to succeed in this evolving market.